Menu
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Carl Zeiss Meditec: Aktie stürzt ab – Quittung für die "Rekordzahlen"?
Carl Zeiss Meditec: Aktie stürzt ab – Quittung für die "Rekordzahlen"?

Rekordjahr für die Carl Zeiss Meditec AG (WKN: 531370): Noch nie erzielte der Medizintechnik-Konzern so gute Zahlen wie in 2018/2019. An der Börse wird die Aktie heute mit einem Kursrutsch um -8,54%

Carl Zeiss Meditec: Aktie stürzt ab – Quittung für die "Rekordzahlen"?
Carl Zeiss Meditec: Aktie stürzt ab – Quittung für die "Rekordzahlen"?

Rekordjahr für die Carl Zeiss Meditec AG (WKN: 531370): Noch nie erzielte der Medizintechnik-Konzern so gute Zahlen wie in 2018/2019. An der Börse wird die Aktie heute mit einem Kursrutsch um -8,54%

LivaNova to Present New Data on Vagus Nerve Stimulation Therapy System at the American Epilepsy Society 2019 Annual Meeting
LivaNova to Present New Data on Vagus Nerve Stimulation Therapy System at the American Epilepsy Society 2019 Annual Meeting


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it will present new registry data from two patient populations benefiting from Vagus Nerve

NanoString Announces Exclusive License of nCounter Diagnostic Assets and Rights to Veracyte
NanoString Announces Exclusive License of nCounter Diagnostic Assets and Rights to Veracyte


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced a strategic transaction to exclusively license select

Nature Medicine Publication Highlights Use of NanoString’s Hyb & Seq Technology to Perform Rapid Genotypic and Phenotypic Antibiotic Susceptibility Testing
Nature Medicine Publication Highlights Use of NanoString’s Hyb & Seq Technology to Perform Rapid Genotypic and Phenotypic Antibiotic Susceptibility Testing


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced the publication of a

EOS imaging RECEIVES U.S. FDA 510(K) CLEARANCE FOR EOSedge™ ITS NEW GENERATION INNOVATIVE IMAGING SYSTEM
EOS imaging RECEIVES U.S. FDA 510(K) CLEARANCE FOR EOSedge™ ITS NEW GENERATION INNOVATIVE IMAGING SYSTEM


Regulatory News:


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191128005574/en/



EOSedge™ (Photo: Business Wire)




EOS imaging

EOS imaging Announces the Upcoming Launch of EOSedge™, Its New Generation Imaging System
EOS imaging Announces the Upcoming Launch of EOSedge™, Its New Generation Imaging System


Regulatory News:


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191126005639/en/



(Photo: Business Wire)




EOS imaging (Paris:EOSI)

Mountain View Medical Group Signs New In-Network Agreement with Humana
Mountain View Medical Group Signs New In-Network Agreement with Humana


Humana Inc. (NYSE: HUM), a leading health and well-being company, has reached an agreement that provides its members in-network access to Mountain View Medical Group in Colorado Springs.


This

Dexcom Announces Upcoming Conference Presentation
Dexcom Announces Upcoming Conference Presentation


DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conference:




  • Steven Pacelli, Executive Vice President, Strategy

Dexcom Announces Upcoming Conference Presentation
Dexcom Announces Upcoming Conference Presentation


DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conference:




  • Steven Pacelli, Executive Vice President, Strategy

Agilent Receives Multiple Life Science Industry Awards for Innovation
Agilent Receives Multiple Life Science Industry Awards for Innovation


Agilent Technologies Inc. (NYSE: A) announced today that it has received two Life Science Industry Awards (LSIA) for ‘Most Innovative New Products in 2019’ from BioInformatics Inc. Since 2002, the

Agilent Technologies Reports Fourth-Quarter and Fiscal Year 2019 Financial Results
Agilent Technologies Reports Fourth-Quarter and Fiscal Year 2019 Financial Results


Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.37 billion for the fourth quarter ended Oct. 31, 2019, up 6% year over year (core(1) growth of 4%).



On a GAAP basis

NanoString to Present at the Evercore ISI 2nd Annual HealthCONx Conference
NanoString to Present at the Evercore ISI 2nd Annual HealthCONx Conference


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is

Humana Honored for Hispanic Inclusion Efforts
Humana Honored for Hispanic Inclusion Efforts


Humana Inc. (NYSE: HUM) has again scored well in the HACR Corporate Inclusion Index, an annual survey by the Hispanic Association on Corporate Responsibility that measures companies’ business

Humana and Epione Health Team Up to Offer a Patient-Centered Experience for Humana Medicare Advantage Members in Oklahoma
Humana and Epione Health Team Up to Offer a Patient-Centered Experience for Humana Medicare Advantage Members in Oklahoma


Humana Inc. (NYSE: HUM), a leading health and well-being company, today announced it has collaborated with Epione Health of Oklahoma, LLC on a value-based agreement designed to offer a coordinated

Agilent Companion Diagnostic Expands CE-IVD mark in Europe to include Head and Neck Squamous Cell Carcinoma (HNSCC)
Agilent Companion Diagnostic Expands CE-IVD mark in Europe to include Head and Neck Squamous Cell Carcinoma (HNSCC)


Agilent Technologies Inc. (NYSE: A) today announced that its PD-L1 IHC 22C3 pharmDx assay is now labeled for use in HNSCC in the European Union.



The assay is CE-IVD–marked as an aid in

Lantheus Holdings to Present at the 31st Annual Piper Jaffray Healthcare Conference
Lantheus Holdings to Present at the 31st Annual Piper Jaffray Healthcare Conference


Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of

Humana Improves Health and Reduces $3.5 Billion in Health Care Costs through Medicare Advantage Value-Based Care Programs
Humana Improves Health and Reduces $3.5 Billion in Health Care Costs through Medicare Advantage Value-Based Care Programs


Helping people living with multiple chronic conditions achieve their optimal whole-person health has been a strategic initiative for Humana Inc. (NYSE: HUM). Today, Humana announced that the

Agilent Announces Applications Open for LabCentral Golden Ticket
Agilent Announces Applications Open for LabCentral Golden Ticket


Agilent Technologies Inc. (NYSE: A) has announced that the nomination process to submit proposals to receive an Agilent-sponsored LabCentral Golden Ticket is open for interested life sciences and

Agilent Technologies Increases Cash Dividend to 18 Cents Per Share
Agilent Technologies Increases Cash Dividend to 18 Cents Per Share


Agilent Technologies, Inc. (NYSE: A) today announced that its board of directors has increased the company’s quarterly dividend to 18 cents per share of common stock, reflecting a 10 percent

Illumina to Webcast Upcoming Investor Conference Presentations
Illumina to Webcast Upcoming Investor Conference Presentations


Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conferences and invited investors to participate via webcast.



Evercore ISI HealthCONx

Illumina to Webcast Upcoming Investor Conference Presentations
Illumina to Webcast Upcoming Investor Conference Presentations


Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conferences and invited investors to participate via webcast.



Evercore ISI HealthCONx

Illumina to Webcast Upcoming Investor Conference Presentations
Illumina to Webcast Upcoming Investor Conference Presentations


Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conferences and invited investors to participate via webcast.



Evercore ISI HealthCONx

Humana and agilon health Expand Relationship, Announce Value-Based Agreements with Physician Groups
Humana and agilon health Expand Relationship, Announce Value-Based Agreements with Physician Groups


Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, announced today that it has signed value-based care agreements with agilon health, which helps physicians and

LivaNova to Restructure its Heart Valve Business Line and End Caisson Transcatheter Mitral Valve Replacement Program
LivaNova to Restructure its Heart Valve Business Line and End Caisson Transcatheter Mitral Valve Replacement Program


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it is ending its Caisson Transcatheter Mitral Valve Replacement (TMVR) program and will